Nexpoint Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Hold |
475,750
| – | – | 0.09% | 58 |
|
|
2025
Q1 | $1.05M | Hold |
475,750
| – | – | 0.09% | 51 |
|
|
2024
Q4 | $728K | Hold |
475,750
| – | – | 0.08% | 48 |
|
|
2024
Q3 | $947K | Hold |
475,750
| – | – | 0.11% | 50 |
|
|
2024
Q2 | $1.67M | Hold |
475,750
| – | – | 0.22% | 38 |
|
|
2024
Q1 | $1.32M | Hold |
475,750
| – | – | 0.2% | 43 |
|
|
2023
Q4 | $809K | Sell |
475,750
-23,381
| -5% | -$39.7K | 0.12% | 37 |
|
|
2023
Q3 | $514K | Hold |
499,131
| – | – | 0.07% | 48 |
|
|
2023
Q2 | $579K | Hold |
499,131
| – | – | 0.08% | 50 |
|
|
2023
Q1 | $754K | Hold |
499,131
| – | – | 0.08% | 47 |
|
|
2022
Q4 | $1.25M | Hold |
499,131
| – | – | 0.1% | 57 |
|
|
2022
Q3 | $2.11M | Hold |
499,131
| – | – | 0.14% | 69 |
|
|
2022
Q2 | $1.39M | Hold |
499,131
| – | – | 0.12% | 69 |
|
|
2022
Q1 | $2.86M | Hold |
499,131
| – | – | 0.37% | 35 |
|
|
2021
Q4 | $4.56M | Hold |
499,131
| – | – | 0.64% | 28 |
|
|
2021
Q3 | $5.34M | Hold |
499,131
| – | – | 0.92% | 25 |
|
|
2021
Q2 | $7.75M | Sell |
499,131
-110,400
| -18% | -$1.71M | 1.69% | 19 |
|
|
2021
Q1 | $9.88M | Sell |
609,531
-111,533
| -15% | -$1.81M | 2.58% | 12 |
|
|
2020
Q4 | $15.3M | Hold |
721,064
| – | – | 5.02% | 4 |
|
|
2020
Q3 | $10.7M | Hold |
721,064
| – | – | 2.42% | 9 |
|
|
2020
Q2 | $10.6M | Sell |
721,064
-56,535
| -7% | -$832K | 2.39% | 9 |
|
|
2020
Q1 | $9.13M | Sell |
777,599
-420,000
| -35% | -$4.93M | 1.72% | 9 |
|
|
2019
Q4 | $28.1M | Sell |
1,197,599
-314,382
| -21% | -$7.39M | 2.14% | 10 |
|
|
2019
Q3 | $28M | Buy |
+1,511,981
| New | +$28M | 1.74% | 12 |
|